Spermosens Total Operating Expenses from 2010 to 2026
| 9R5 Stock | 0 0.0002 16.67% |
Total Operating Expenses | First Reported 2010-12-31 | Previous Quarter 10.5 M | Current Value 12.5 M | Quarterly Volatility 3.5 M |
Check Spermosens financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Spermosens' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Interest Expense of 762 K or Selling General Administrative of 4.8 M, as well as many indicators such as . Spermosens financial statements analysis is a perfect complement when working with Spermosens Valuation or Volatility modules.
Spermosens | Total Operating Expenses |
The Total Operating Expenses trend for Spermosens AB offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Spermosens is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Spermosens' Total Operating Expenses Growth Pattern
Below is the plot of the Total Operating Expenses of Spermosens AB over the last few years. It is the total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses. Spermosens' Total Operating Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Spermosens' overall financial position and show how it may be relating to other accounts over time.
| Total Operating Expenses | 10 Years Trend |
|
Total Operating Expenses |
| Timeline |
Spermosens Total Operating Expenses Regression Statistics
| Arithmetic Mean | 8,021,097 | |
| Geometric Mean | 7,520,379 | |
| Coefficient Of Variation | 43.82 | |
| Mean Deviation | 2,586,490 | |
| Median | 6,189,000 | |
| Standard Deviation | 3,514,473 | |
| Sample Variance | 12.4T | |
| Range | 12.9M | |
| R-Value | 0.61 | |
| Mean Square Error | 8.3T | |
| R-Squared | 0.37 | |
| Significance | 0.01 | |
| Slope | 424,806 | |
| Total Sum of Squares | 197.6T |
Spermosens Total Operating Expenses History
About Spermosens Financial Statements
Spermosens stakeholders use historical fundamental indicators, such as Spermosens' Total Operating Expenses, to determine how well the company is positioned to perform in the future. Although Spermosens investors may analyze each financial statement separately, they are all interrelated. For example, changes in Spermosens' assets and liabilities are reflected in the revenues and expenses on Spermosens' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Spermosens AB. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Operating Expenses | 10.5 M | 12.5 M |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Spermosens Stock
Spermosens financial ratios help investors to determine whether Spermosens Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Spermosens with respect to the benefits of owning Spermosens security.